It is a pharma public limited company based in New Delhi, Delhi, India, established in 2020.
2020 | New Delhi, Delhi, India | ActiveBhagwan Dass Pharmaceutical Limited, a active public limited company, was established on 21 January 2020 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24304DL2020PLC360532. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Prajwal Arora (Director), Rekha Sareen (Director), Namrata Arora (Director). Past directors included Praveen Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1495, G/F Shankar Niwas, Building Niwas Bhagirath Palace, New Delhi, Delhi, 110006.
U24304DL2020PLC360532
360532
21 January 2020
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Bhagwan Dass Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prajwal Arora | Director | 21 Jan 2020 | Current |
| Rekha Sareen | Director | 21 Jan 2020 | Current |
| Namrata Arora | Director | 24 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bhagwan Dass Pharmaceutical Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 35.97% decrease. The company also saw a substantial improvement in profitability, with a 47.05% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Bhagwan Dass Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Bhagwan Dass Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bhagwan Dass Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhagwan Dass Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bhagwan Dass Pharmaceutical Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Namrata Arora was appointed as a Director was appointed as a Director on 24 Aug 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
Bhagwan Dass Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Prajwal Arora was appointed as a Director was appointed as a Director on 21 Jan 2020 & has been associated with this company since 5 years 10 months . was documented.
The activity Rekha Sareen was appointed as a Director was appointed as a Director on 21 Jan 2020 & has been associated with this company since 5 years 10 months . was completed.
The activity Bhagwan Dass Pharmaceutical Limited was registered on 21 Jan 2020 with Roc Delhi & aged 5 years 10 months as per MCA records. was completed.
The CIN of Bhagwan Dass Pharmaceutical Limited is U24304DL2020PLC360532.
Bhagwan Dass Pharmaceutical Limited is headquartered at 1495, G/F Shankar Niwas, Building Niwas Bhagirath Palace, New Delhi, Delhi, 110006.
Bhagwan Dass Pharmaceutical Limited was incorporated on 21 January 2020.
The current directors of Bhagwan Dass Pharmaceutical Limited are
The primary industry of Bhagwan Dass Pharmaceutical Limited is Pharma.
Bhagwan Dass Pharmaceutical Limited is unlisted.
The authorized capital of Bhagwan Dass Pharmaceutical Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX